Welcome to LookChem.com Sign In|Join Free
  • or
(R)-2-Hydroxy-4-phenylbutyric acid, also known as (R)-HPB, is a chiral organic compound with the molecular formula C10H12O3. It is an off-white solid and is characterized by the presence of a hydroxyl group and a phenyl ring attached to a butyric acid backbone. (R)-2-Hydroxy-4-phenylbutyric acid exhibits unique stereochemistry, with the R-configuration at the chiral center, which is crucial for its biological activity and applications.

29678-81-7

Post Buying Request

29678-81-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

29678-81-7 Usage

Uses

Used in Pharmaceutical Industry:
(R)-2-Hydroxy-4-phenylbutyric acid is used as a key intermediate in the synthesis of angiotensin-converting enzyme (ACE) inhibitors. These ACE inhibitors are essential in the development of medications for the treatment of hypertension and heart failure. The R-configuration of (R)-HPB plays a vital role in the biological activity of the final drug products, ensuring their efficacy in managing blood pressure and cardiovascular health.
Used in Chemical Synthesis:
(R)-2-Hydroxy-4-phenylbutyric acid serves as a versatile reactant in various chemical synthesis processes. Its unique structure allows it to participate in a range of reactions, such as esterification, amidation, and condensation, making it a valuable building block for the creation of complex organic molecules and pharmaceutical agents.

Check Digit Verification of cas no

The CAS Registry Mumber 29678-81-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,6,7 and 8 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 29678-81:
(7*2)+(6*9)+(5*6)+(4*7)+(3*8)+(2*8)+(1*1)=167
167 % 10 = 7
So 29678-81-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O3/c11-9(10(12)13)7-6-8-4-2-1-3-5-8/h1-5,9,11H,6-7H2,(H,12,13)/t9-/m1/s1

29678-81-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H52804)  (R)-(-)-2-Hydroxy-4-phenylbutyric acid, 97%   

  • 29678-81-7

  • 1g

  • 532.0CNY

  • Detail
  • Alfa Aesar

  • (H52804)  (R)-(-)-2-Hydroxy-4-phenylbutyric acid, 97%   

  • 29678-81-7

  • 5g

  • 2130.0CNY

  • Detail
  • Aldrich

  • (420085)  (R)-2-Hydroxy-4-phenylbutyricacid  99%

  • 29678-81-7

  • 420085-100MG

  • 926.64CNY

  • Detail

29678-81-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (R)-2-Hydroxy-4-phenylbutyric acid

1.2 Other means of identification

Product number -
Other names (2R)-2-hydroxy-4-phenylbutanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:29678-81-7 SDS

29678-81-7Relevant academic research and scientific papers

Efficient Synthesis of D-Phenylalanine from L-Phenylalanine via a Tri-Enzymatic Cascade Pathway

Lu, Cui,Zhang, Sheng,Song, Wei,Liu, Jia,Chen, Xiulai,Liu, Liming,Wu, Jing

, p. 3165 - 3173 (2021/06/09)

D-phenylalanine is an important intermediate in food and pharmaceutical industries. Here, to enable efficient D-phenylalanine biosynthesis from L-phenylalanine, a tri-enzymatic cascade was designed and reconstructed in vivo. The activity of Proteus vulgaris meso-diaminopimelate dehydrogenase (PvDAPDH) toward phenyl pyruvic acid was identified as the limiting step. To overcome, the tension in the phenyl pyruvic acid side-chain, PvDAPDH was engineered, generating PvDAPDHW121A/R181S/H227I, whose catalytic activity of 6.86 U mg?1 represented an 85-fold increase over PvDAPDH. Introduction of PvDAPDHW121A/R181S/H227I, P. mirabilis L-amino acid deaminase, and Bacillus megaterium glucose dehydrogenase in E. coli enabled the production of 57.8 g L?1 D-phenylalanine in 30 h, the highest titer to date using 60 g L?1 L-phenylalanine as starting substrate, which meant a 96.3 % conversion rate and >99 % enantioselectivity on a 3-L scale. The proposed tri-enzymatic cascade provides a novel potential bio-based approach for industrial production of D-phenylalanine from cheap amino acids.

Chirality switching in the enantioseparation of 2-hydroxy-4-phenylbutyric acid: Role of solvents in selective crystallization of the diastereomeric salt

Hirose, Takuji,Kodama, Koichi,Shitara, Hiroaki,Yi, Meng

, (2020/03/04)

Chirality switching was induced by solvents in the enantioseparation of 2-hydroxy-4-phenylbutyric acid (HPBA) via diastereomeric salt formation with an enantiopure aminoalcohol. The (S)-salt was crystallized from butanol solutions and the (R)-salt was obt

Highly Efficient Deracemization of Racemic 2-Hydroxy Acids in a Three-Enzyme Co-Expression System Using a Novel Ketoacid Reductase

Xue, Ya-Ping,Wang, Chuang,Wang, Di-Chen,Liu, Zhi-Qiang,Zheng, Yu-Guo

, p. 1 - 13 (2018/04/26)

Enantiopure 2-hydroxy acids (2-HAs) are important intermediates for the synthesis of pharmaceuticals and fine chemicals. Deracemization of racemic 2-HAs into the corresponding single enantiomers represents an economical and highly efficient approach for synthesizing chiral 2-HAs in industry. In this work, a novel ketoacid reductase from Leuconostoc lactis (LlKAR) with higher activity and substrate tolerance towards aromatic α-ketoacids was discovered by genome mining, and then its enzymatic properties were characterized. Accordingly, an engineered Escherichia coli (HADH-LlKAR-GDH) co-expressing 2-hydroxyacid dehydrogenase, LlKAR, and glucose dehydrogenase was constructed for efficient deracemization of racemic 2-HAs. Most of the racemic 2-HAs were deracemized to their (R)-isomers at high yields and enantiomeric purity. In the case of racemic 2-chloromandelic acid, as much as 300 mM of substrate was completely transformed into the optically pure (R)-2-chloromandelic acid (> 99% enantiomeric excess) with a high productivity of 83.8 g L?1 day?1 without addition of exogenous cofactor, which make this novel whole-cell biocatalyst more promising and competitive in practical application.

Asymmetric synthesis of (S)-dihydrokavain from l-malic acid

Eskici, Mustafa,Karanfil, Abdullah,?zer, M. Sabih,Kabak, Yal??n,Durucasu, ?nci

, p. 2382 - 2390 (2018/10/20)

A practical and efficient asymmetric synthesis of (S)-dihydrokavain from known ethyl (S)-2-hydroxy-4-phenylbutanoate which is, in turn, readily available from l-malic acid as a cheap chiral pool material is described using regioselective ring-opening of the 1,2-cyclic sulfate with lithium-3,3,3-triethoxypropiolate and subsequent HgO/H2SO4-mediated lactonization as the key steps. Its opposite enantiomer (R)-dihydrokavain was also synthesized from d-malic acid using the same sequences of reactions for the purpose of optical purity determination.

Preparation method of (R)-2-hydroxyl-4-phenyl butyric acid

-

Paragraph 0023, (2017/07/21)

The invention discloses a preparation method of (R)-2-hydroxyl-4-phenyl butyric acid. The method comprises the following steps: carrying out catalytic reduction on 2-oxo-4-phenyl butyric acid-L-menthyl ester in an alcohol system to obtain (R)-2-hydroxyl-4

Chloramphenicol base chemistry. Part 10: Asymmetric synthesis of α-hydroxy chiral alcohols via intramolecular Michael additions of γ-hydroxy-α, β-unsaturated enones with chloramphenicol base derived bifunctional urea organocatalysts

Wang, Haifeng,Yan, Linjie,Wu, Yan,Chen, Fener

, p. 2793 - 2800 (2017/04/14)

We have developed the chloramphenicol base urea-catalyzed intramolecular Michael addition of γ-hydroxy-α, β-unsaturated enones. The oxidation of the resulting products provided facile access to the corresponding α-hydroxy chiral alcohols with good efficiency and enantioselectivity, with the reaction displaying broad substrate scope. The utility of this methodology was further demonstrated by the synthesis of (R)-2-hydroxy-4-phenylbutanoate, which is a key building block for the construction of the ACE inhibitor benazepril hydrochloride.

Method for preparing lisinopril intermediate

-

Paragraph 0047; 0051, (2017/04/03)

The invention provides a method for preparing a lisinopril intermediate. The lisinopril intermediate is (R)-2-hydroxyl-4-phenylbutyrate. The method has the advantages that the lisinopril intermediate is made of inexpensive and easily available raw materials which are benzaldehyde and pyruvic acid, four-step efficient reaction including condensation, biological enzyme catalytic asymmetric reduction, double-bond hydrogenation and esterification is carried out on the benzaldehyde and the pyruvic acid, and accordingly an optically pure target product (R)-HPBE [(R)-2-hydroxyl-4-phenylbutyrate] can be ultimately obtained at the overall yield of 83%.

Asymmetric hydrogenation reaction of alpha-ketoacids compound

-

Paragraph 0037; 0045, (2016/10/10)

The invention relates to the technical field of organic chemistry, especially to an asymmetric hydrogenation reaction of an alpha-ketoacids compound. The asymmetric hydrogenation reaction comprises a scheme shown in the description. In the scheme, R1 is phenyl, substituted phenyl, naphthyl, substituted naphthyl, C1-C6 alkyl, or aralkyl; a substituent group is C1-C6 alkyl, C1-C6 alkoxy, or halogen; and the number of the substituent group is 1-3. In the scheme, M is a chiral spiro-pyridylamino phosphine ligand iridium complex having a structure shown in the description. In the structure, R is hydrogen, 3-methyl, 4-tBu, or 6-methyl.

Direct asymmetric hydrogenation of α-keto acids by using the highly efficient chiral spiro iridium catalysts

Yan, Pu-Cha,Xie, Jian-Hua,Zhang, Xiang-Dong,Chen, Kang,Li, Yuan-Qiang,Zhou, Qi-Lin,Che, Da-Qing

supporting information, p. 15987 - 15990 (2015/02/19)

A new efficient and highly enantioselective direct asymmetric hydrogenation of α-keto acids employing the Ir/SpiroPAP catalyst under mild reaction conditions has been developed. This method might be feasible for the preparation of a series of chiral α-hydroxy acids on a large scale.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 29678-81-7